Alaunos Therapeutics (TCRT) Q2 2026 Earnings

Screener

Reported August 14, 2026 · Before market open

EPS-$0.41

Next report

Nov 17, 2026 (in 2 months)

EPS estimate-$15.75

Versus estimates

Revenue

Q4 2025$3.0KIn line Q1 2025$2.0K

Diluted EPS

Q2 2026-$0.41

Q1 2026-$0.59 Q4 2025-$0.40Beat by $3.29 Q3 2025-$0.55Beat by $4.35 Q2 2025-$0.63Beat by $4.70 Q1 2025-$0.67Beat by $5.77

FAQ

When did Alaunos Therapeutics report Q2 2026 earnings?: Alaunos Therapeutics (TCRT) reported Q2 2026 earnings on August 14, 2026 before market open.
What were Alaunos Therapeutics's Q2 2026 revenue and EPS?: Alaunos Therapeutics reported eps of $-0.41 for Q2 2026.
How did Alaunos Therapeutics's Q2 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 34.9% from $-0.63.
Where can I find Alaunos Therapeutics's Q2 2026 SEC filings?: You can read the 10-Q periodic report (0001193125-26-352421) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Alaunos Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk